Autor: |
Jong Seok Lee, Santiago Viteri Ramirez, Chester Lin, Ji-Youn Han, Harold N. Keer, Hye Ryun Kim, Antoinette J. Wozniak, In-Jae Oh, D. Ross Camidge, Mohammad Azab, Benjamin Besse, Dae Ho Lee, Joan H. Schiller, Myung-Ju Ahn, Nathan A. Pennell, Erin M. Bertino |
Rok vydání: |
2016 |
Předmět: |
|
Zdroj: |
Journal of Clinical Oncology. 34:9059-9059 |
ISSN: |
1527-7755 0732-183X |
Popis: |
9059Background: Crizotinib (C) was the first approved ALK inhibitor for use in in ALK positive (pos) NSCLC, but resistance ultimately develops through both ALK-related and other signaling pathways.... |
Databáze: |
OpenAIRE |
Externí odkaz: |
|